glycine has been researched along with Lung Diseases, Interstitial in 7 studies
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Many of these patients die from interstitial lung disease despite discontinuation of the drug and addition of corticosteroid treatment." | 2.40 | [Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation]. ( Ishioka, S, 1997) |
| "However, interstitial lung disease (ILD) is a very rare yet potentially fatal complication of RTX treatment." | 1.48 | Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder. ( Ahn, SH; Kim, SM; Sung, JJ, 2018) |
| "Respiratory failure was relieved within 2 weeks following treatment There was no four-fold rise in screen viral titers and screening investigations of autoantibodies were negative." | 1.33 | [Two cases of acute respiratory failure due to idiopathic interstitial pneumonia successfully treated with sivelestat sodium hydrate and steroid therapy]. ( Chida, K; Enomoto, N; Imokawa, S; Nagayama, M; Sano, T; Suda, T; Todate, A; Uchiyama, H; Yasuda, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H | 1 |
| Nakayama, H | 1 |
| Yokose, T | 1 |
| Nagashima, T | 1 |
| Morohoshi, T | 1 |
| Tajiri, M | 1 |
| Maehara, T | 1 |
| Watanabe, K | 1 |
| Arai, H | 1 |
| Yamamoto, T | 1 |
| Woo, T | 1 |
| Nishii, T | 1 |
| Ishikawa, Y | 1 |
| Morita, S | 1 |
| Masuda, M | 1 |
| Ahn, SH | 1 |
| Kim, SM | 1 |
| Sung, JJ | 1 |
| Sakai, M | 1 |
| Takenami, T | 1 |
| Otsuka, T | 1 |
| Hayashi, N | 1 |
| Yoshino, K | 1 |
| Matsumoto, S | 1 |
| Okamoto, H | 1 |
| Imokawa, S | 1 |
| Sano, T | 1 |
| Todate, A | 1 |
| Uchiyama, H | 1 |
| Yasuda, K | 1 |
| Nagayama, M | 1 |
| Enomoto, N | 1 |
| Suda, T | 1 |
| Chida, K | 1 |
| Morooka, T | 1 |
| Morioka, M | 1 |
| Nomura, Y | 1 |
| Furuya, H | 1 |
| Kobayashi, J | 1 |
| Kitamura, S | 1 |
| Ishioka, S | 1 |
2 reviews available for glycine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
[How can we monitor and treat patients with acute exacerbations of idiopathic interstitial pneumonia].
Topics: Acute-Phase Reaction; Anti-Inflammatory Agents; Antigens; Antigens, Neoplasm; Biomarkers; Clinical T | 1996 |
[Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation].
Topics: Animals; Antineoplastic Agents; Bleomycin; Drug Administration Schedule; Glycine; Humans; Lung Disea | 1997 |
1 trial available for glycine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
A prophylaxis study of acute exacerbation of interstitial pneumonia after lung cancer surgery.
Topics: Aged; Anti-Inflammatory Agents; Female; Glycine; Humans; Lung; Lung Diseases, Interstitial; Lung Neo | 2020 |
4 other studies available for glycine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
Topics: Aquaporin 4; Autoantibodies; Female; Glycine; Humans; Immunoglobulin G; Immunologic Factors; Lung Di | 2018 |
[Anesthetic management of posterior lumbar spinal fusion in a patient suspected of having acute exacerbation of chronic interstitial pneumonia].
Topics: Acute-Phase Reaction; Aged; Airway Management; Anesthesia; Chronic Disease; Disease Progression; Eme | 2014 |
[Two cases of acute respiratory failure due to idiopathic interstitial pneumonia successfully treated with sivelestat sodium hydrate and steroid therapy].
Topics: Acute Disease; Aged; Drug Therapy, Combination; Female; Glycine; Humans; Lung Diseases, Interstitial | 2006 |
[Case of fulminant idiopathic interstitial pneumonia treated by sodium siverlestat (Elaspol) and steroid pulse therapy following extracorporeal lung assist (ECLA)].
Topics: Extracorporeal Membrane Oxygenation; Glycine; Humans; Lung Diseases, Interstitial; Male; Methylpredn | 2007 |